MannKind Corporation (MNKD) News
Track canonical SquawkNews coverage tagged to MNKD, MannKind Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
MNKD Revenue Jumps 43% YoY
MNKD revenue increases 43% year over year
EQUITY | Aug 05, 2026, 08:06 PM UTC
L
MNKD - MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
MNKD - MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 05, 2026, 08:01 PM UTC
L
MNKD - MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation o
MNKD - MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
EQUITY | Jul 29, 2026, 10:30 AM UTC
L
MNKD +5.4% premarket after FDA approves Co's single-use autoinjector to treat fluid buildup
MNKD +5.4% premarket after FDA approves Co's single-use autoinjector to treat fluid buildup
REGULATION | Jul 24, 2026, 10:44 AM UTC
L
ELVT SNY OTSKY MNKD OTLK VTRS Here are the key confirmed or reported upcoming PDUFA (Prescription Drug User Fee Act) target action dates for
ELVT SNY OTSKY MNKD OTLK VTRS Here are the key confirmed or reported upcoming PDUFA (Prescription Drug User Fee Act) target action dates for remainder of month: --ELVT expected around 7/23 – Drug rivoceranib + camrelizum
EQUITY | Jul 20, 2026, 05:31 PM UTC
M
MNKD Awarded Grant
MannKind awarded grant to support pediatric trial of Afrezza in youth with newly-diagnosed type 1 diabetes
EQUITY | Jun 23, 2026, 01:01 PM UTC